Catalyst Crew Technologies Corp.

LataMed AI Corp. filed a Certificate of Change on July 2, 2026, to implement a five-for-one (5:1) forward stock split, reclassifying each outstanding common share into five shares. Concurrently, the company increased its authorized common stock from 700 million to 3.5 billion shares and its authorized preferred stock from 300 million to 1.5 billion shares.

LataMed AI Corp. (formerly Catalyst Crew Technologies Corp.) announced a strategic pivot towards AI-enabled healthcare technology solutions focused on Latin America. This transition included the acquisition of proprietary healthcare technology assets for $7.93 million in common stock and the establishment of a Venezuelan subsidiary. The company reported a net loss of $52,813 for Q1 2026, an increase from the prior year, and faces substantial doubt about its ability to continue as a going concern. Management changes also occurred, with Kevin Rodan Levy appointed CEO and Carlos Peña as CFO.

LataMed AI Corp. (formerly Catalyst Crew Technologies Corp.) announced that its Board of Directors approved the designation of a new Series C Voting Preferred Stock. The company filed a Certificate of Designation with the Nevada Secretary of State to establish the rights, preferences, and limitations of this new series. Key terms include 5,000,000 authorized shares, twenty votes per share, non-convertibility, and a liquidation preference senior to common stock.

Catalyst Crew Technologies Corp. officially changed its corporate name to LataMed AI Corp. The company filed a Certificate of Amendment to its Articles of Incorporation with the Nevada Secretary of State on April 28, 2026, making the name change effective immediately. This amendment solely impacts the company's name, with all other provisions of its Articles of Incorporation remaining the same.

Catalyst Crew Technologies Corp. filed an amendment to its 2025 Annual Report, detailing a significant strategic pivot to AI-enabled healthcare technology solutions. This shift followed a change in control on February 17, 2026, where Kevin Rodan Levy acquired a controlling interest and was appointed CEO and sole director. The company subsequently acquired AI healthcare assets from Dr. Levy and a Venezuelan subsidiary, Inversiones Long 33, C.A., to support its new focus on Latin American markets. As a development-stage company, it reported no revenue for 2025 and 2024, and its auditor expressed substantial doubt about its ability to continue as a going concern.

Catalyst Crew Technologies Corp. filed its annual report on Form 10-K for the fiscal year ended December 31, 2025. The company reported an aggregate market value of voting and non-voting common equity held by non-affiliates of approximately $6,204,354 as of the last business day of its most recently completed second fiscal quarter. CCTC is classified as a non-accelerated filer, a smaller reporting company, and an emerging growth company.

Catalyst Crew Technologies Corp. acquired intellectual property related to an artificial intelligence-enabled healthcare analytics platform from its CEO, Kevin Rodan Levy, on February 17, 2026. The acquisition included proprietary software, machine learning models, datasets, and Venezuelan patent registrations for CardioAI, PulmoAI, and NeuroAI technologies. Subsequently, on March 23, 2026, the company acquired 100% of Inversiones Long 33, C.A., a Venezuelan subsidiary, also from its CEO. The acquired intellectual property was then formally assigned to this subsidiary on April 7, 2026, as an internal reorganization step without additional consideration.

Catalyst Crew Technologies Corp. acquired intellectual property related to an AI-enabled healthcare analytics platform, including CardioAI, PulmoAI, and NeuroAI technologies, from its CEO on February 17, 2026. Subsequently, on March 23, 2026, the company acquired 100% of Inversiones Long 33, C.A., a Venezuelan corporation, also from its CEO. The acquired intellectual property was then formally assigned to this new subsidiary on April 7, 2026, as an internal reorganization to align the company's operating structure in Venezuela, with no additional consideration paid.

Catalyst Crew Technologies Corp. (CCTC) has appointed Carlos Peña, 38, as its new Chief Financial Officer, effective March 31, 2026. Mr. Peña brings over ten years of experience in accounting, financial management, and audit support, including recent roles as an independent accountant and Supervisor of Administration and Finance for Aerovip. His appointment is expected to strengthen the company's financial leadership and operational oversight. Peña's diverse background across various financial functions and industries positions him to contribute to CCTC's strategic financial objectives.